1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Aceragen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations Sodium Fusidate, Placebo - Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | Phase 2 | Withdrawn | Aceragen | 2023-02-10 | 2023-07-19 |
Cystic Fibrosis (1)
Fusidic Acid (1)
United States (1)